S&P 500   3,335.32 (-0.65%)
DOW   27,843.00 (-0.21%)
QQQ   267.81 (-0.93%)
AAPL   108.29 (-1.86%)
MSFT   200.02 (-1.42%)
FB   255.92 (+0.43%)
GOOGL   1,464.14 (-1.54%)
AMZN   2,968.81 (-1.33%)
NVDA   491.30 (-1.45%)
TSLA   441.09 (+4.17%)
BABA   274.26 (-0.53%)
CGC   16.48 (+0.49%)
GE   7.03 (-0.28%)
MU   51.31 (+0.65%)
AMD   75.48 (-1.40%)
T   29.11 (+0.14%)
F   7.33 (+0.69%)
ACB   6.66 (-3.34%)
GILD   64.80 (-0.37%)
NFLX   469.84 (-0.08%)
DIS   130.24 (+0.02%)
BAC   25.49 (+0.55%)
BA   165.65 (-1.12%)
S&P 500   3,335.32 (-0.65%)
DOW   27,843.00 (-0.21%)
QQQ   267.81 (-0.93%)
AAPL   108.29 (-1.86%)
MSFT   200.02 (-1.42%)
FB   255.92 (+0.43%)
GOOGL   1,464.14 (-1.54%)
AMZN   2,968.81 (-1.33%)
NVDA   491.30 (-1.45%)
TSLA   441.09 (+4.17%)
BABA   274.26 (-0.53%)
CGC   16.48 (+0.49%)
GE   7.03 (-0.28%)
MU   51.31 (+0.65%)
AMD   75.48 (-1.40%)
T   29.11 (+0.14%)
F   7.33 (+0.69%)
ACB   6.66 (-3.34%)
GILD   64.80 (-0.37%)
NFLX   469.84 (-0.08%)
DIS   130.24 (+0.02%)
BAC   25.49 (+0.55%)
BA   165.65 (-1.12%)
S&P 500   3,335.32 (-0.65%)
DOW   27,843.00 (-0.21%)
QQQ   267.81 (-0.93%)
AAPL   108.29 (-1.86%)
MSFT   200.02 (-1.42%)
FB   255.92 (+0.43%)
GOOGL   1,464.14 (-1.54%)
AMZN   2,968.81 (-1.33%)
NVDA   491.30 (-1.45%)
TSLA   441.09 (+4.17%)
BABA   274.26 (-0.53%)
CGC   16.48 (+0.49%)
GE   7.03 (-0.28%)
MU   51.31 (+0.65%)
AMD   75.48 (-1.40%)
T   29.11 (+0.14%)
F   7.33 (+0.69%)
ACB   6.66 (-3.34%)
GILD   64.80 (-0.37%)
NFLX   469.84 (-0.08%)
DIS   130.24 (+0.02%)
BAC   25.49 (+0.55%)
BA   165.65 (-1.12%)
S&P 500   3,335.32 (-0.65%)
DOW   27,843.00 (-0.21%)
QQQ   267.81 (-0.93%)
AAPL   108.29 (-1.86%)
MSFT   200.02 (-1.42%)
FB   255.92 (+0.43%)
GOOGL   1,464.14 (-1.54%)
AMZN   2,968.81 (-1.33%)
NVDA   491.30 (-1.45%)
TSLA   441.09 (+4.17%)
BABA   274.26 (-0.53%)
CGC   16.48 (+0.49%)
GE   7.03 (-0.28%)
MU   51.31 (+0.65%)
AMD   75.48 (-1.40%)
T   29.11 (+0.14%)
F   7.33 (+0.69%)
ACB   6.66 (-3.34%)
GILD   64.80 (-0.37%)
NFLX   469.84 (-0.08%)
DIS   130.24 (+0.02%)
BAC   25.49 (+0.55%)
BA   165.65 (-1.12%)
Log in
NYSE:ALB

Albemarle Stock Forecast, Price & News

$99.95
-0.50 (-0.50 %)
(As of 09/18/2020 12:03 PM ET)
Add
Compare
Today's Range
$99.52
Now: $99.95▼
$101.00
50-Day Range
$82.46
MA: $90.99▼
$99.65
52-Week Range
$48.89
Now: $99.95▼
$100.97
Volume10,185 shs
Average Volume1.57 million shs
Market Capitalization$10.63 billion
P/E Ratio24.26
Dividend Yield1.57%
Beta1.41
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The company's Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. Its Catalysts segment offers performance catalyst solutions comprising hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. The company was founded in 1994 and is headquartered in Charlotte, North Carolina.
Read More
Albemarle logo

Beat the Market (BTM) Rank™

Analyst Opinion: 2.0Community Rank: 2.7Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

2.23 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSE
Industry Plastics materials & resins
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Current SymbolNYSE:ALB
Previous Symbol
CUSIP01265310
CIK915913
Webwww.albemarle.com
Phone980-299-5700

Debt

Debt-to-Equity Ratio0.74
Current Ratio1.61
Quick Ratio1.01

Price-To-Earnings

Trailing P/E Ratio24.26
Forward P/E Ratio28.64
P/E Growth3.51

Sales & Book Value

Annual Sales$3.59 billion
Price / Sales2.96
Cash Flow$8.22 per share
Price / Cash Flow12.16
Book Value$38.61 per share
Price / Book2.59

Profitability

EPS (Most Recent Fiscal Year)$6.04
Net Income$533.23 million
Net Margins12.99%
Return on Equity13.33%
Return on Assets5.73%

Miscellaneous

Employees6,000
Outstanding Shares106,358,000
Market Cap$10.63 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$99.95
-0.50 (-0.50 %)
(As of 09/18/2020 12:03 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALB News and Ratings via Email

Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Albemarle (NYSE:ALB) Frequently Asked Questions

How has Albemarle's stock price been impacted by Coronavirus?

Albemarle's stock was trading at $70.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ALB stock has increased by 43.3% and is now trading at $100.44.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Albemarle?

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 5 sell ratings, 13 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Albemarle.

When is Albemarle's next earnings date?

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Albemarle.

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) posted its quarterly earnings results on Wednesday, August, 5th. The specialty chemicals company reported $0.86 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.72 by $0.14. Albemarle had a net margin of 12.99% and a return on equity of 13.33%.
View Albemarle's earnings history.

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle declared a quarterly dividend on Tuesday, July 14th. Shareholders of record on Friday, September 18th will be paid a dividend of $0.385 per share on Thursday, October 1st. This represents a $1.54 annualized dividend and a dividend yield of 1.53%. The ex-dividend date is Thursday, September 17th.
View Albemarle's dividend history.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle updated its third quarter 2020 After-Hours earnings guidance on Wednesday, August, 5th. The company provided EPS guidance of for the period. The company issued revenue guidance of $700-775 million, compared to the consensus revenue estimate of $717.55 million.

What price target have analysts set for ALB?

24 analysts have issued 12-month price targets for Albemarle's shares. Their forecasts range from $40.00 to $116.00. On average, they anticipate Albemarle's stock price to reach $77.81 in the next year. This suggests that the stock has a possible downside of 22.5%.
View analysts' price targets for Albemarle.

Are investors shorting Albemarle?

Albemarle saw a drop in short interest during the month of August. As of August 14th, there was short interest totaling 10,530,000 shares, a drop of 13.6% from the July 30th total of 12,190,000 shares. Based on an average daily trading volume, of 1,180,000 shares, the short-interest ratio is currently 8.9 days. Approximately 10.0% of the company's shares are sold short.
View Albemarle's Short Interest.

Who are some of Albemarle's key competitors?

Some companies that are related to Albemarle include Sherwin-Williams (SHW), Ecolab (ECL), Valaris (VAL), Celanese (CE), International Flavors & Fragrances (IFF), RPM International (RPM), Ashland Global (ASH), NewMarket (NEU), Quaker Chemical (KWR), W. R. Grace & Co (GRA), Balchem (BCPC), HB Fuller (FUL), Stepan (SCL), PolyOne (POL) and Sensient Technologies (SXT).
View all competitors.

What other stocks do shareholders of Albemarle own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), NVIDIA (NVDA), Alibaba Group (BABA) and Rogers Communications (RCI).

Who are Albemarle's key executives?

Albemarle's management team includes the following people:
  • Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 54)
  • Mr. Scott A. Tozier, Exec. VP & CFO (Age 53)
  • Mr. Donald J. LaBauve Jr., VP, Corp. Controller & Chief Accounting Officer (Age 52)
  • Ms. Karen G. Narwold, Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 59)
  • Mr. David Ryan, VP of Corp. Strategy & Investor Relations

What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Who are Albemarle's major shareholders?

Albemarle's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.89%), FMR LLC (2.56%), Bank of New York Mellon Corp (2.42%), ProShare Advisors LLC (1.23%), KAMES CAPITAL plc (1.00%) and US Bancorp DE (0.88%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam and Scott Tozier.
View institutional ownership trends for Albemarle.

Which institutional investors are selling Albemarle stock?

ALB stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Grantham Mayo Van Otterloo & Co. LLC, Eastern Bank, Cibc World Markets Corp, Robecosam AG, Federated Hermes Inc., Toronto Dominion Bank, and Advisor Group Holdings Inc.. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam, and Scott Tozier.
View insider buying and selling activity for Albemarle.

Which institutional investors are buying Albemarle stock?

ALB stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Avalon Investment & Advisory, US Bancorp DE, Marathon Asset Management LLP, Ensign Peak Advisors Inc, Zweig DiMenna Associates LLC, Perseverance Asset Management International, and Hardman Johnston Global Advisors LLC. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow, and Eric Norris.
View insider buying and selling activity for Albemarle.

How do I buy shares of Albemarle?

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $100.44.

How big of a company is Albemarle?

Albemarle has a market capitalization of $10.68 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis. Albemarle employs 6,000 workers across the globe.

What is Albemarle's official website?

The official website for Albemarle is www.albemarle.com.

How can I contact Albemarle?

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]

This page was last updated on 9/18/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.